Press Releases

iAssay and DDTD Tag Team Against COVID-19

San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served organizations. This step enables organizations to provide DDTD’s high performance COVID-19 serology tests along with automatic digitized reads that are transmitted simultaneously and securely using iAssay’s SimpleCloud™ AWS portal to health records. This will satisfy domestic and international compliance mandates as-well as global health goals. In the United States, the Federal and State requirements support public health and epidemiologic surveillance with the Department of Health and Human Services (HHS) requiring that both positive and negative COVID-19 test results be reported to them or a resulting $1,000 fine for the first violation, and $500 fine per day for ongoing violations.  iAssay’s SimpleTest™ sends test results automatically, supporting HHS compliance.   Read more…